BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the availability of the U.S. Food and Drug Administration (FDA) cleared ...

BD Life Sciences - a division of Becton, Dickinson and Company or BD BDX-- recently announced FDA approval for BD MAX Enteric Parasite Panel, to be used in the BD MAX System. The BD MAX system is a ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the BD MAX Enteric Parasite Panel, the latest in a suite of assays that help to diagnose ...

SPARKS, Maryland, May 12, 2014 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD ...

BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX™ Enteric Bacterial ...

FRANKLIN LAKES, N.J., Nov. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)) a leading global medical technology company, today announced it has received U.S. Food and Drug ...

FRANKLIN LAKES, N.J., June 5, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its newly developed molecular test ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a new molecular test for detecting most of the harmful intestinal ...

GI infections cause billions of illnesses and more than 1.7 million deaths globally each year, disproportionately affecting young children, older adults, and immunocompromised people i. In the United ...